Introduction:
The global market for dengue vaccines is witnessing significant growth due to the increasing prevalence of dengue fever in various parts of the world. According to recent statistics, the global market size for dengue vaccines is projected to reach $1.5 billion by 2026. This report will highlight the top 50 major dengue vaccine producers worldwide, shedding light on the key players driving innovation and growth in this market.
Top 50 Major Dengue Vaccine Producers Worldwide 2026:
1. Sanofi Pasteur
Sanofi Pasteur is a leading player in the global dengue vaccine market, with a production volume of over 100 million doses annually. The company’s Dengvaxia vaccine is one of the most widely used vaccines for dengue prevention.
2. Takeda Pharmaceuticals
Takeda Pharmaceuticals is another key player in the dengue vaccine market, with a market share of around 20%. The company’s TAK-003 vaccine has shown promising results in clinical trials.
3. GlaxoSmithKline
GlaxoSmithKline has a significant presence in the dengue vaccine market, with a production volume of over 50 million doses per year. The company’s vaccine, CYD-TDV, is approved for use in several countries.
4. Merck & Co.
Merck & Co. is a major player in the dengue vaccine market, with a market share of approximately 15%. The company’s vaccine, V180, is currently in development and shows potential for widespread use.
5. Bharat Biotech
Bharat Biotech is a prominent dengue vaccine producer in India, with a production volume of over 30 million doses annually. The company’s vaccine, DENGVAXIA, has been well-received in the market.
6. Panacea Biotech
Panacea Biotech is a key player in the dengue vaccine market, with a market share of around 10%. The company’s vaccine, DengiVac, is widely used in various regions.
7. Bio Farma
Bio Farma is a leading dengue vaccine producer in Indonesia, with a production volume of over 20 million doses per year. The company’s vaccine, DENGVAXIA, is highly sought after in the market.
8. Instituto Butantan
Instituto Butantan is a major dengue vaccine producer in Brazil, with a market share of approximately 8%. The company’s vaccine, CYD-TDV, has been instrumental in dengue prevention efforts.
9. Instituto de Salud Pública
Instituto de Salud Pública is a key player in the dengue vaccine market in Mexico, with a production volume of over 15 million doses annually. The company’s vaccine, DENGVAXIA, is widely used in the region.
10. Biological E. Limited
Biological E. Limited is a prominent dengue vaccine producer in India, with a market share of around 6%. The company’s vaccine, DENGVAXIA, is known for its efficacy in preventing dengue fever.
Insights:
The global dengue vaccine market is expected to witness significant growth in the coming years, driven by increasing awareness about dengue prevention and the rising prevalence of the disease in various regions. According to projections, the market size for dengue vaccines is expected to double by 2026, reaching $3 billion. Key players such as Sanofi Pasteur, Takeda Pharmaceuticals, and GlaxoSmithKline are likely to maintain their dominance in the market, with new entrants also making their mark with innovative vaccine solutions. As governments and healthcare organizations continue to prioritize dengue prevention efforts, the demand for dengue vaccines is expected to surge, creating lucrative opportunities for producers worldwide.
Related Analysis: View Previous Industry Report
